Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil vs Tamsulosin in BPH and ED
NCT05818670Phase 4Completed
- Sponsor
- Mansoura University
- Start
- Nov 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tadalafil in benign prostatic hyperplasia (BPH) and erectile dysfunction (ED) (2 arms), sponsored by Mansoura University. Primary endpoint: Drug discontinuation rate at 12 months. Started Nov 2020; status: completed.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT05818670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05818670.